Ergoteles’s PhenomeX Inc. Common Stock CELL Stock Holding History

Ergoteles’s Portfolio CELL Stock Details CELL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-26,800	Closed	-$133K	–	2142
2022 Q2	$133K	Sell	26,800 -28,600	-52%	-$150K	﹤0.01%	1446
2022 Q1	$394K	Buy	+55,400	New	+$458K	0.01%	757
2021 Q1	–	Sell	-22,893	Closed	-$2.05M	–	1135
2020 Q4	$2.05M	Buy	+22,893	New	+$1.93M	0.07%	246

Other funds holding CELL

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

NIMC

Nierenberg Investment Management Company Camas, Washington $201M AUM 36.3% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ergoteles's CELL Position: Q3 2022 in Review

Ergoteles sold out of PhenomeX Inc. Common Stock (CELL) in Q3 2022, closing a stake of 26,800 shares — an estimated $133K sold.

Ergoteles first reported a position in CELL in Q4 2020 and held it in 3 quarters. The position peaked at $2.05M in Q4 2020. 113 funds tracked by Wall St. Rank hold CELL as of Q3 2022.

Ergoteles reported no remaining PhenomeX Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Ergoteles sold 26,800 PhenomeX Inc. Common Stock shares in Q3 2022, an estimated $133K.
Ergoteles first reported a position in PhenomeX Inc. Common Stock in Q4 2020 and held it in 3 quarters.
Ergoteles's PhenomeX Inc. Common Stock position peaked at $2.05M in Q4 2020.
113 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q3 2022.

Based on Ergoteles's 13F filing for Q3 2022, filed 14 Nov 2022.